Childhood Rhabdomyosarcoma With Mixed Embryonal and Alveolar Features
2 clinical trials · Condition
◉ Watch Childhood Rhabdomyosarcoma With Mixed Embryonal and Alveolar Features
| Record | Firm | Date |
|---|---|---|
| Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma (NCT01222715) | National Cancer Institute (NCI) | 2010-10-01 |
| Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma (NCT00720174) | National Cancer Institute (NCI) | 2008-06-01 |
Track Childhood Rhabdomyosarcoma With Mixed Embryonal and Alveolar Features automatically
Every clearance here is in the API, with alerts when new ones post.